Jump to main content
Jump to site search

Issue 3, 2016
Previous Article Next Article

eCF309: a potent, selective and cell-permeable mTOR inhibitor

Author affiliations

Abstract

Kinase inhibitors capable of blocking the phosphorylation of protein substrates with high selectivity are essential to probe and elucidate the etiological role of such molecules and their signalling pathways. By addressing these biochemical questions in disease relevant cell-based and in vivo models, strong pharmacological evidence can be generated towards validating or disproving a target hypothesis. Pharmacological studies can also provide fundamental information to identify appropriate biomarkers and rational drug combination strategies and thereby facilitate clinical translation. However, due to the high number of kinases encoded by the human genome (>500) and their highly conserved catalytic domains, the development of such an elite class of inhibitors—a.k.a. high-quality chemical probes—represents a major challenge. Through a ligand-based inhibitor design, focused library synthesis and phenotypic screening to prioritize compounds with potent cell activity, we recently identified a cell cycle inhibitor with micromolar potency that inhibits mTOR kinase activity. Following a rapid lead optimization campaign, we report the development of eCF309, an mTOR inhibitor displaying low nanomolar potency both in vitro and in cells and an excellent selectivity profile (S-score (35%) = 0.01 at 10 μM).

Graphical abstract: eCF309: a potent, selective and cell-permeable mTOR inhibitor

Back to tab navigation

Supplementary files

Publication details

The article was received on 26 Oct 2015, accepted on 10 Dec 2015 and first published on 22 Dec 2015


Article type: Research Article
DOI: 10.1039/C5MD00493D
Citation: Med. Chem. Commun., 2016,7, 471-477
  • Open access: Creative Commons BY license
  •   Request permissions

    eCF309: a potent, selective and cell-permeable mTOR inhibitor

    C. Fraser, N. O. Carragher and A. Unciti-Broceta, Med. Chem. Commun., 2016, 7, 471
    DOI: 10.1039/C5MD00493D

    This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements